These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 8829021
21. 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma. Feldman RM, Stewart RH, Stewart WC, Jia G, Smugar SS, Galet VA. Curr Med Res Opin; 2008 Aug; 24(8):2403-12. PubMed ID: 18627642 [Abstract] [Full Text] [Related]
22. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. Sezgin Akçay Bİ, Güney E, Bozkurt KT, Unlü C, Akçali G. J Ocul Pharmacol Ther; 2013 Dec; 29(10):882-6. PubMed ID: 24180628 [Abstract] [Full Text] [Related]
23. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension. Reis R, Queiroz CF, Santos LC, Avila MP, Magacho L. Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466 [Abstract] [Full Text] [Related]
24. A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol. Oral to Topical CAI Study Group. Hutzelmann JE, Polis AB, Michael AJ, Adamsons IA. Acta Ophthalmol Scand; 1998 Dec; 76(6):717-22. PubMed ID: 9881560 [Abstract] [Full Text] [Related]
25. Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices. Pajic B, Conductors of the Swiss COSOPT Survey (CSCS). Curr Med Res Opin; 2003 Dec; 19(2):95-101. PubMed ID: 12740152 [Abstract] [Full Text] [Related]
26. Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension. Balfour JA, Wilde MI. Drugs Aging; 1997 May; 10(5):384-403. PubMed ID: 9143858 [Abstract] [Full Text] [Related]
27. A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life. Strohmaier K, Snyder E, Adamsons I. J Am Optom Assoc; 1998 Jul; 69(7):441-51. PubMed ID: 9697378 [Abstract] [Full Text] [Related]
28. Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma. Konstas AG, Maltezos A, Bufidis T, Hudgins AG, Stewart WC. Eye (Lond); 2000 Feb; 14 ( Pt 1)():73-7. PubMed ID: 10755105 [Abstract] [Full Text] [Related]
29. Comparing the fixed combination dorzolamide-timolol (Cosopt) to concomitant administration of 2% dorzolamide (Trusopt) and 0.5% timolol -- a randomized controlled trial and a replacement study. Francis BA, Du LT, Berke S, Ehrenhaus M, Minckler DS, Cosopt Study Group. J Clin Pharm Ther; 2004 Aug; 29(4):375-80. PubMed ID: 15271105 [Abstract] [Full Text] [Related]
30. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group. Adamsons IA, Polis A, Ostrov CS, Boyle JE. J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861 [Abstract] [Full Text] [Related]
31. Latanoprost versus combined timolol and dorzolamide. Bron AM, Emmerich KH. Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S148-54. PubMed ID: 12204712 [Abstract] [Full Text] [Related]
32. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group. Silver LH. Am J Ophthalmol; 1998 Sep; 126(3):400-8. PubMed ID: 9744373 [Abstract] [Full Text] [Related]
33. Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol. Stewart WC, Halper LK, Johnson-Pratt L, Polis A, Hartenbaum D. J Ocul Pharmacol Ther; 2002 Jun; 18(3):211-20. PubMed ID: 12099542 [Abstract] [Full Text] [Related]
34. Topical dorzolamide 2%/timolol 0.5% ophthalmic solution: a review of its use in the treatment of glaucoma and ocular hypertension. Frampton JE, Perry CM. Drugs Aging; 2006 Jun; 23(12):977-95. PubMed ID: 17154662 [Abstract] [Full Text] [Related]
35. Experience with Cosopt, the fixed combination of timolol and dorzolamide, after switch from free combination of timolol and dorzolamide, in Swiss ophthalmologists' offices. Gugleta K, Orgül S, Flammer J. Curr Med Res Opin; 2003 Jun; 19(4):330-5. PubMed ID: 12841926 [Abstract] [Full Text] [Related]
36. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Wilkerson M, Cyrlin M, Lippa EA, Esposito D, Deasy D, Panebianco D, Fazio R, Yablonski M, Shields MB. Arch Ophthalmol; 1993 Oct; 111(10):1343-50. PubMed ID: 8216014 [Abstract] [Full Text] [Related]
37. Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension. Cvetkovic RS, Perry CM. Drugs Aging; 2003 Oct; 20(12):919-47. PubMed ID: 14565787 [Abstract] [Full Text] [Related]
38. A comparison of dorzolamide-timolol combination versus the concomitant drugs. Choudhri S, Wand M, Shields MB. Am J Ophthalmol; 2000 Dec; 130(6):832-3. PubMed ID: 11124307 [Abstract] [Full Text] [Related]
39. Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt) in patients with open-angle glaucoma or ocular hypertension maintained on timolol therapy. Shin D. Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S163-8. PubMed ID: 10665519 [Abstract] [Full Text] [Related]
40. A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension. Coleman AL, Lerner F, Bernstein P, Whitcup SM. Ophthalmology; 2003 Dec; 110(12):2362-8. PubMed ID: 14644719 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]